Join Our Lung Cancer Screening Symposium

Mark your calendar and join us at ESTI 2024 for the symposium "Exploring New Horizons in Lung Cancer Screening," made possible by the Canon Medical Academy (May 11, 12:00–13:00).

This session, featuring experts such as Prof. Marie Pierre Revel, Prof. Y. Ohno, and Prof. C. Schaefer-Prokop, will delve into the latest advancements in CT imaging and their profound impact on the early detection and accurate diagnosis of lung cancer.

Attend the symposium to gain crucial insights into the evolving trends and technologies shaping the future of thoracic imaging. This symposium promises a deep exploration of innovative approaches that enhance diagnostic precision and improve patient outcomes in lung cancer screening.

Exploring New Horizons in Lung Cancer Screening | Program

12:00–13:00 (CEST) | Room #1

Title: Exploring New Horizons in Lung Cancer Screening
Subtitle: Cutting-Edge CT Imaging and Emerging Trends

Lung cancer screening plays a crucial role in early detection and subsequent treatment, significantly improving patient outcomes. This symposium delves into the importance of lung cancer screening, highlighting experiences and advancements in CT imaging technologies. Insights on screening practices and recent developments in CT technology that enhance image quality while reducing radiation exposure will be discussed. The symposium culminates in a Q&A, providing a platform to discuss challenges and opportunities in lung cancer screening, thus paving the way for more effective preventive strategies.

  • Moderator: Prof. Marie Pierre Revel
  • Lung Cancer Screening with Cutting-Edge CT Technology | Prof. Y. Ohno
  • Advances in CT Technology: How They Affect Screening for Lung Cancer | Prof. C. Schaefer-Prokop
  • Q&A
Why Should You Attend

  • To understand how advancements in CT technology, including AI integration and ultra-low-dose examinations, are revolutionizing lung cancer screening.
  • To learn how CT technology advancements enhance lung cancer screening by reducing radiation and improving accuracy for informed clinical decisions.

INFORMATION ON SPEAKERS AND THEIR PRESENTATIONS

sou
Moderator: Prof. Marie Pierre Revel, MD, PhD Professor of Radiology, Head of Radiology Department
Cochin Hospital
Paris, France
sou
Speaker: Prof. Y. Ohno, MD, PhD Professor and Chairman of Diagnostic Radiology, Chairman of Joint
Research Laboratory of Advanced Medical Imaging
Fujita Health University School of Medicine
Toyoake, Japan

Presentation: Lung Cancer Screening with Cutting-Edge CT Technology

This presentation provides an overview of lung cancer screening in Japan, highlighting advancements in CT technology. It explores cutting-edge methods such as lung imaging with AI, high-res imaging, and ultra-low-dose examinations. These technologies may help to improve the progress in early detection and diagnosis, potentially revolutionizing lung cancer screening practices.
sou
Speaker: Prof. C. Schaefer-Prokop, MD, PhD Radiologist, Head of Imaging Department
Meander Medical Centre (and RadboudUMC)
Amersfoort, the Netherlands

Presentation: Advances in CT Technology: How They Affect Screening for Lung Cancer

This presentation explores the impact of advancements in CT technology on lung cancer screening. It examines how innovative technologies, such as SilverBeam and Deep Learning Reconstruction, have lowered the radiation dose while simultaneously enhancing diagnostic accuracy and screening efficiency.

The discussion delves into the implications for early detection and treatment outcomes, shedding light on the evolving landscape of lung nodule management in the era of cutting-edge imaging technologies.


Disclaimers

  • The opinions expressed in this material are solely those of the presenter and not necessarily those of Canon Medical Systems. Canon Medical Systems does not guarantee the accuracy or reliability of the information provided herein.
  • The clinical results, performance and views described in this video/webinar are the experience of the clinician. Results may vary due to clinical setting, patient presentation and other factors. Many factors could cause the actual results and performance of Canon Medical’s products to be materially different from any of the aforementioned.
  • Some products shown might not be available in all regulatory jurisdictions, please consult with your local Canon sales office for availability in your region.

Contact Us